UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: C | D | E | F | H | I | J | L | P | S | V | W
Number of items: 27.

C

Cong, Y; Pawlisz, E; Bryant, P; Balan, S; Laurine, E; Tommasi, R; Singh, R; (2012) Site-specific PEGylation at histidine tags. Bioconjug Chem , 23 (2) pp. 248-263. 10.1021/bc200530x.

D

Da Costa Rocha, I; Edwards, S; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Quality and safety of herbal products: Part 1 - new legislation and production. The Pharmaceutical Journal , 288 685 - 686.

Da-Costa-Rocha, I; Edwards, S; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Quality and safety of herbal products: Part 1 - New legislation and production. Pharmaceutical Journal , 288 (7708-7) pp. 685-686.

Da-Costa-Rocha, I; Edwards, S; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Quality and safety of herbal products: Part 2 — keeping patients safe. The Pharmaceutical Journal , 288 33 - 34.

de la Fuente, M; Lozano, MV; Uchegbu, IF; Schätzlein, AG; (2012) Nanostructures as tools for CNS delivery. In: Alonso, MJ and Csaba, N, (eds.) Nanostructured Biomaterials for Overcoming Biological Barriers. Royal Society of Chemistry: Cambridge.

E

Edwards, S; Da Costa Rocha, I; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Use and efficacy of herbal medicines: Part 1 — historical and traditional use. The Pharmaceutical Journal , 289 161 - 162.

Edwards, S; Da Costa Rocha, I; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Use and efficacy of herbal medicines: Part 2 — clinical effectiveness. The Pharmaceutical Journal , 289 270 - 271.

Edwards, S; Da-Costa-Rocha, I; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Use and efficacy of herbal medicines: Part 1 - Historical and traditional use. Pharmaceutical Journal , 289 (7717) pp. 161-162.

Edwards, S; Da-Costa-Rocha, I; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Use and efficacy of herbal medicines: Part 2 - Clinical effectiveness. Pharmaceutical Journal , 289 (7722) pp. 270-271.

Edwards, S; Da-Costa-Rocha, I; Lawrence, MJ; Cable, C; Heinrich, M; (2012) A reappraisal of herbal medicinal products. Nursing Times , 108 (39) 24 - 27.

Edwards, S; Da-Costa-Rocha, I; Lawrence, MJ; Cable C, C; Heinrich, M; (2012) A reappraisal of herbal medicinal products. Nurs Times , 108 (39) 24 - 27.

Edwards, SE; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Where do herbal medicines belong? Part 1 – an overview of CAM. The Pharmaceutical Journal , 288 pp. 565-566.

Edwards, SE; Lawrence, MJ; Cable, C; Heinrich, M; (2012) Where do herbal medicines belong? Part 2 – herbal medicines reappraised. The Pharmaceutical Journal , 288 pp. 627-628.

Escaja, N; Viladoms, J; Garavís, M; Villasante, A; Pedroso, E; González, C; (2012) A minimal i-motif stabilized by minor groove G:T:G:T tetrads. Nucleic Acids Research , 40 (22) pp. 11737-11747. 10.1093/nar/gks911.

F

Falodun, A; Sheng-Xiang, Q; Parkinson, G; Gibbons, S; (2012) Isolation and characterization of a new anticancer diterpenoid from Jatropha gossypifolia. Pharmaceutical Chemistry Journal pp. 1-4.

H

Haider, SM; Neidle, S; (2012) Chapter 2: Molecular dynamics and force field based methods for studying quadruplex nucleic acids. RSC Biomolecular Sciences pp. 33-52.

Heinrich, M; Dhanji, T; Casselman, I; (2012) Açaí (Euterpe oleracea Mart.) - A phytochemical and pharmacological assessment of the species health claims. Zeitschrift fur Phytotherapie , 33 (3) pp. 140-150. 10.1055/s-0032-1309259.

I

Innocent, N; Cousins, SL; Stephenson, FA; (2012) NMDA receptor/amyloid precursor protein interactions: a comparison between wild-type and amyloid precursor protein mutations associated with familial Alzheimer's disease. Neurosci Lett , 515 (2) pp. 131-136. 10.1016/j.neulet.2012.03.029.

J

Jachak, SM; Roy, SK; Gupta, S; Ahirrao, P; Gibbons, S; (2012) Small-molecule efflux pump inhibitors from natural products as a potential source of antimicrobial agents. pp. 62-76.

L

Llalasta, A; Schätzlein, AG; Uchegbu, IF; (2012) The blood brain barrier and drug transport. In: Alonso, MJ and Csaba, N, (eds.) Nanostructured Biomaterials for Overcoming Biological Barriers. Royal Society of Chemistry: Cambridge.

P

Prieto, JM; (2012) Haplophyllum A. Juss, a rich source of bioactive natural principles. In: Bioactive Compounds: Types, Biological Activities and Health Effects. (pp. 341-380).

Prieto, JM; Ogunsina, MO; Novak, A; Joshi, A; Kokai, J; Rocha, IDC; de Santayana, MP; (2012) Comparative study of the in vitro bioactivities of Bupleurum rigidum and B. fruticescens. Nat Prod Commun , 7 (6) 757 - 760.

S

Santander-Ortega, MJ; Uchegbu, IF; Schätzlein, AG; (2012) Dendrimer-Based Gene Delivery Systems: Administration Routes and In Vivo Evaluation. In: Dendrimer-Based Drug Delivery Systems: From Theory to Practice. (pp. 329-354).

Suter, A; Saller, R; Riedi, E; Heinrich, M; (2012) El fruto de sabal mejora los síntomas de la hiperplasia benigna de próstata y la disfunción sexual. Resultados de un estudio piloto. Revista de Fitoterapia , 12 (2) pp. 119-133.

Suter, A; Saller, R; Riedi, E; Heinrich, M; (2012) Saw palmetto berry improves BPH symptoms and sexual dysfunctions. Results from a pilot trial | El fruto de sabal mejora los síntomas de la hiperplasia benigna de próstata y la disfunción sexual. Resultados de un estudio piloto. Revista de Fitoterapia , 12 (2) pp. 119-133.

V

Viladoms, J; Fedor, MJ; (2012) The glmS Ribozyme Cofactor is a General Acid–Base Catalyst. Journal of the American Chemical Society , 134 (46) 19043-19049-19043-19049. 10.1021/ja307021f.

W

Wangteeraprasert, R; Lipipun, V; Gunaratnam, M; Neidle, S; Gibbons, S; Likhitwitayawuid, K; (2012) Bioactive compounds from Carissa spinarum. Phytotherapy Research , 26 (10) pp. 1496-1499. 10.1002/ptr.4607.

This list was generated on Sun Dec 11 05:41:54 2016 GMT.